Office Based Labs (OBL) Market by Product Type, by Application, by Geography – Forecast to 2028

Report - ID613010 | 10 July, 2019 | Healthcare | 100 pages | Report Type (Global) | Publisher Name - RFM

Market Analysis Insights 
The office based labs (OBL) market is expected to grow globally with an estimated CAGR 9.2% to reach USD 19.04 billion by 2028. Increasing trend of surgical procedures being performed in outpatient settings backed by rising incidence of various vascular diseases, high patient satisfaction with a focused and dedicated team of doctors and Preference to minimally invasive procedures are the main market drivers of this market.

 Market Segment
The Market is segmented based on Modality
• Single Specialty
• Multi-specialty
• Hybrid

The Market is segmented based on Service
• Peripheral Vascular Intervention
• Endovascular Intervention
• Cardiac
• Interventional Radiology
• Venous

The Market is segmented based on Specialist
• Vascular Surgeons
• Interventional Cardiologists
• Interventional Radiologists

The above segmentation is covered for all countries and regions listed below
• North and South America
o U.S.
o Canada
o Mexico
o Brazil
o Rest of Americas
• Europe
o Germany
o France
o U.K.
o Italy 
o Spain
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o Australia
o Rest of APAC
• Middle East and Africa
Competitive Research
The major players in the office based labs (OBL) market are Koninklijke Philips N.V., Siemens Healthcare Private Limited, General Electronic Company,  Abbott, Medtronic,  Boston Scientific Corporation , Cardiovascular System, Inc., Surgery Partners, Tenet Healthcare
Leave a Message